Cargando…
P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL)
Autores principales: | Ghobadi, Armin, Aldoss, Ibrahim, Maude, Shannon, S Wayne, Alan, Bhojwani, Deepa, Bajel, Ashish, Dholaria, Bhagirathbhai, Faramand, Rawan, Mattison, Ryan, Rettig, Michael, Bakkacha, Ouiam, Muth, John, Pannunzio, Angela, Ramsey, Brett, Mcnulty, Eileen, Cooper, Matthew, Davidson-Moncada, Jan, Jacobs, Kenneth, Dipersio, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428339/ http://dx.doi.org/10.1097/01.HS9.0000968336.17893.02 |
Ejemplares similares
-
PB2498: A PHASE 1 STUDY OF WU-NK-101 IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
por: Cashen, Amanda, et al.
Publicado: (2023) -
Positioning blinatumomab in the frontline of adult B-cell acute lymphoblastic leukemia treatment
por: Pourhassan, Hoda, et al.
Publicado: (2023) -
News from LBL
por: Furman, M A
Publicado: (1994) -
Study of Extramedullary Lymphoblastic Lymphoma (LBL) Diagnosed by Flowcytometric Immunophenotyping (FCI) on Fine Needle Aspirate (FNA) Sample—A Case Series of 18 Cases
por: Makde, Manjiri M., et al.
Publicado: (2023) -
Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
por: Lee, Kum Ja, et al.
Publicado: (2016)